1. Home
  2. NAMS vs HCC Comparison

NAMS vs HCC Comparison

Compare NAMS & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • HCC
  • Stock Information
  • Founded
  • NAMS 2019
  • HCC 2015
  • Country
  • NAMS Netherlands
  • HCC United States
  • Employees
  • NAMS N/A
  • HCC N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • HCC Coal Mining
  • Sector
  • NAMS Health Care
  • HCC Energy
  • Exchange
  • NAMS Nasdaq
  • HCC Nasdaq
  • Market Cap
  • NAMS 3.1B
  • HCC 3.3B
  • IPO Year
  • NAMS N/A
  • HCC 2017
  • Fundamental
  • Price
  • NAMS $36.14
  • HCC $62.97
  • Analyst Decision
  • NAMS Strong Buy
  • HCC Buy
  • Analyst Count
  • NAMS 10
  • HCC 7
  • Target Price
  • NAMS $43.70
  • HCC $71.17
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • HCC 710.9K
  • Earning Date
  • NAMS 11-06-2025
  • HCC 11-05-2025
  • Dividend Yield
  • NAMS N/A
  • HCC 0.50%
  • EPS Growth
  • NAMS N/A
  • HCC N/A
  • EPS
  • NAMS N/A
  • HCC 0.77
  • Revenue
  • NAMS $64,006,000.00
  • HCC $1,221,350,000.00
  • Revenue This Year
  • NAMS N/A
  • HCC N/A
  • Revenue Next Year
  • NAMS $1.67
  • HCC $42.35
  • P/E Ratio
  • NAMS N/A
  • HCC $83.74
  • Revenue Growth
  • NAMS 762.15
  • HCC N/A
  • 52 Week Low
  • NAMS $14.06
  • HCC $38.00
  • 52 Week High
  • NAMS $41.47
  • HCC $75.15
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 60.09
  • HCC 47.55
  • Support Level
  • NAMS $34.34
  • HCC $61.87
  • Resistance Level
  • NAMS $37.21
  • HCC $64.95
  • Average True Range (ATR)
  • NAMS 2.47
  • HCC 2.34
  • MACD
  • NAMS -0.34
  • HCC -0.49
  • Stochastic Oscillator
  • NAMS 46.32
  • HCC 16.59

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.

Share on Social Networks: